Endothelial dysfunction in transplant: defibrotide for VOD
Speaking at the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, talks abou...
Author: VJHemOnc
Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Autologous transplant advances: induction and maintenance
Autologous stem cell transplantation can prove to be safer in some instances compared with allogeneic transplantation for treating hematological malignancies, as the risk of graft-versus-host disease ...
Author: VJHemOnc
Added: 07/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 16, 2018 Category: Cancer & Oncology Source Type: podcasts
Case study: acquired von Willebrand disease in allogeneic BMT
Acquired von Willebrand disease is a rare condition that has been reported in post-autologous bone marrow transplant (BMT) patients, though never in post-allogeneic BMT. Here, HaemSTAR Co-lead Pip Nic...
Author: VJHemOnc
Added: 07/12/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 12, 2018 Category: Cancer & Oncology Source Type: podcasts
Treating aplastic anemia in developing countries
Aplastic anemia (AA) results in T-cells attacking bone marrow stem cells, causing loss of all blood cell types. Generally, this condition is treated with a stem cell transplant in combination with ant...
Author: VJHemOnc
Added: 07/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Hodgkin lymphoma: when autologous transplant is unsuccessful
Autologous transplant is unsuccessful in ~50% of Hodgkin lymphoma (HL) patients. Here, Stephen Robinson, MBBS, MRCP, MRCPath, PhD, of University Hospitals Bristol NHS Foundation Trust, Bristol, UK, de...
Author: VJHemOnc
Added: 07/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 6, 2018 Category: Cancer & Oncology Source Type: podcasts
Treating aplastic anemia in developing countries
Aplastic anemia (AA) results in T-cells attacking bone marrow stem cells, causing loss of all blood cell types. Generally, this condition is treated with a stem cell transplant in combination with ant...
Author: VJHemOnc
Added: 07/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2018 Category: Cancer & Oncology Source Type: podcasts
IMPACT: expediting transplantation trials
The next 4 years are going to be exciting and productive for transplant research across a broad range of hematological malignancies. As explained here by David Marks, MBBS, PhD, FRACP, FRCPath, of Uni...
Author: VJHemOnc
Added: 06/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 27, 2018 Category: Cancer & Oncology Source Type: podcasts
Launching Phase 2 Trial In Multi-Center Fashion | Currently Evaluated in Bone Marrow Transplantation
Aman Chauhan, MBBS, University of Kentucky shares Launching Phase 2 Trial In Multi-Center Fashion | Currently Evaluated in Bone Marrow Transplantation at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Launching Phase 2 Trial In Multi-Center Fashion & #124; Currently Evaluated in Bone Marrow Transplantation
Aman Chauhan, MBBS, University of Kentucky shares Launching Phase 2 Trial In Multi-Center Fashion | Currently Evaluated in Bone Marrow Transplantation at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2018 Category: Cancer & Oncology Source Type: podcasts
Intubation Techniques for Difficult Airways, qSOFA Validity for Sepsis in Low-Resource Countries, Trachea Transplantation, and more.
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 05, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - June 5, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
The devastating effects of relapsed or refractory AML
Dealing with patients with refractory acute myeloid leukemia (AML) or with those who have relapsed, is challenging, and stem cell transplantation is one of the few therapies that can be offered in the...
Author: VJHemOnc
Added: 05/29/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 29, 2018 Category: Cancer & Oncology Source Type: podcasts
Paul Richardson, MD - Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT
Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - May 22, 2018 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
The devastating effects of relapsed or refractory AML
Dealing with patients with refractory acute myeloid leukemia (AML) or with those who have relapsed, is challenging, and stem cell transplantation is one of the few therapies that can be offered in the...
Author: VJOncology
Added: 05/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Managing rare post-transplant complications: thrombotic microangiopathy
Thrombotic microangiopathy (TMA) is a rare complication that may arise post-transplant in patients, however, incidence of TMA has increased in recent years with no clear reason. Speaking at the 2018 E...
Author: VJHemOnc
Added: 05/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 15, 2018 Category: Cancer & Oncology Source Type: podcasts
